Glanish Jude Martis and Santosh L. Gaonkar
RSC Adv., 2025,15, 8213-8243
From themed collection:
2025 Reviews in RSC Advances
Abstract
Recent advances in synthetic strategies of isoxazoles and their role in medicinal chemistry.
Afia Saleem, Hamza Khan, Syed Majid Bukhari, Lotfi Ben Tahar, Umar Farooq and Ahson Jabbar Shaikh
Dalton Trans., 2025,54, 16508-16524
Abstract
Lone pair electrons dominate the binding of isoxazole derivatives to metal oxide surfaces, while aromatic groups show reduced affinity, revealing a fundamental shift from metal to metal oxide surface interactions.
Neha Jangra, Bharti Sharma, Deepak Kumar and Archana Kapoor
RSC Med. Chem., 2025,16, 3893-3958
Abstract
The study summarizes the findings from the last eight years of research on heterocyclic core-based epidermal growth factor receptor inhibitors. This provides an invaluable tool for oncology drug discovery.
Xin-Qi Zhu, Zhi-Xu Meng, Bo Zhou, Ming-Yu Teng and Long-Wu Ye
Chem. Soc. Rev., 2025,54, 2137-2153
Abstract
This review summarizes the latest trends and developments of isoxazole-enabled alkyne amination reactions and their applications in divergent heterocycle synthesis.
Danish Ansari, Manoj K. Jaiswal, Mangal S. Yadav, Vinay K. Pandey, Mayank Singh and Vinod K. Tiwari
Org. Biomol. Chem., 2025,23, 4045-4057
Abstract
The work describes a practical approach for the one-pot access of 4-aryl- or glycosyl NH-1,2,3-triazoles from a multicomponent reaction involving aldehydes, nitroalkanes, and NaN3 in the presence of 5 mol% of SMA as a biocompatible catalyst.